Analyst Nathan Weinstein works at CITI and is covering the the Healthcare sector with 50 price targets and ratings documented since 2019 spanning on 17 stocks.
Nathan Weinstein's average stock forecast success ratio is 8.33% with an average time for price targets to be met of 30.5 days.
Most recent stock forecast was given on DRIO, DarioHealth Corp at 18-Aug-2022.
Analyst best performing recommendations are on ORMP (ORAMED PHARMACEUTICALS INC).
The best stock recommendation documented was for ORMP (ORAMED PHARMACEUTICALS INC) at 6/8/2021. The price target of $20 was fulfilled within 62 days with a profit of $6.15 (44.4%) receiving and performance score of 7.16.
Average potential price target upside
Currently, out of the existing stock ratings of Nathan Weinstein - 26 which are a Buy (96.3%), 1 which are a Hold (3.7%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
20
$18.25 (1042.86%)
26 days ago
0/3 (0%)
$27.5 (477.89%)
Buy
9
$7.25 (414.29%)
24
29 days ago
0/2 (0%)
$9.45 (235.20%)
Buy
2 months 14 days ago
0/1 (0%)
$17.08 (114.48%)
Hold
9
$7.25 (414.29%)
17
1 years 2 months 10 days ago
0/2 (0%)
$4.36 (58.08%)
Buy
27
1 years 2 months 10 days ago
0/1 (0%)
$10.17 (60.43%)
